Cala Health
Focus: Cala Health is a neurological biotech company founded in 2019, developing wearable neuromodulation devices for conditions like essential tremor, Parkinson's disease, and atrial fibrillation. The company is early-stage with a focused device-based portfolio.
Profile data last refreshed 37m ago · AI intelligence enriched 2w ago
Open Jobs
6-5 this month
Cooling — net -5 jobs in 30d
2 added, 7 removed. Slower than typical.
Should You Work at Cala Health?
AI assessmentBest for early-career engineers and commercial professionals seeking equity upside in a capital-efficient device play, but not for those seeking financial stability or clinical-stage maturity.
Why Work Here
- Join a pioneering neuromodulation company at ground level with 9 active clinical trials across multiple high-impact neurological indications
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Cala Device
Essential TremorClinical Trials (1)
NCT05480215Symptomatic Relief of Action Tremor With Cala Trio Using Trio+ Bands
N/AHelp build intelligence for Cala Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.